ReviewInternational immunopharmacology2021

Anti-VEGF agents: As appealing targets in the setting of COVID-19 treatment in critically ill patients.

Adeleh Sahebnasagh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.